<p>Privia Health Group（納斯達克代碼：PRVA - 獲取免費報告）在週四發佈的報告中，Truist Financial 的股票分析師將其目標價格從 27.00 美元上調至 28.00 美元，Benzinga 報道。該券商目前對該股票給予 “買入” 評級。Truist Financial 的目標價格意味着該股票相較於之前的收盤價有 22.83% 的潛在上漲空間。</p>
<p>獲取 <strong>Privia Health Group</strong> 的提醒：</p>
<p>PRVA 近期成為多篇報告的主題。Stephens 在 1 月 2 日的報告中重新發布了 “超配” 評級，並將 Privia Health Group 的目標價格設定為 26.00 美元。Canaccord Genuity Group 在 2 月 28 日的研究報告中將 Privia Health Group 的目標價格從 29.00 美元上調至 30.00 美元，並給予該公司 “買入” 評級。Macquarie 在 12 月 16 日的研究報告中開始覆蓋 Privia Health Group，給予 “跑贏大盤” 評級和 25.00 美元的價格目標。Piper Sandler 在 2 月 28 日的報告中將 Privia Health Group 的目標價格從 25.00 美元上調至 40.00 美元，並給予該公司 “超配” 評級。最後，JMP Securities 在 2 月 28 日的研究報告中將 Privia Health Group 的目標價格設定為 29.00 美元。一位股票研究分析師對該股票給予持有評級，十三位給予買入評級，兩位給予強烈買入評級。根據 MarketBeat.com 的數據，該公司目前的共識評級為 “買入”，共識目標價格為 26.73 美元。</p>
<p><strong>查看我們關於 Privia Health Group 的最新股票報告</strong></p>
<h2>Privia Health Group 股價下跌 1.1%</h2>
<p>PRVA 股票在週四開盤價為 22.80 美元。該公司的 50 日簡單移動平均線為 23.73 美元，200 日簡單移動平均線為 21.41 美元。Privia Health Group 的 1 年最低價為 15.92 美元，1 年最高價為 26.04 美元。該公司的市值為 27.7 億美元，市盈率為 227.97，市盈增長比率為 3.47，貝塔值為 0.88。</p>
<h2>Privia Health Group 的內部活動</h2>
<p>在其他新聞中，首席財務官 David Mountcastle 在 4 月 2 日（星期三）出售了 5,630 股公司的股票。股票以平均價格 22.38 美元出售，總價值為 125,999.40 美元。交易完成後，首席財務官現在持有 179,676 股公司股票，價值為 4,021,148.88 美元。此交易代表其持股減少了 3.04%。該交易已在向 SEC 提交的文件中披露，文件可通過此超鏈接獲取。公司內部人士目前持有 14.20% 的股票。</p>
<h2>機構資金流入和流出</h2>
<p>一些機構投資者和對沖基金最近對 PRVA 的持倉進行了調整。Rhumbline Advisers 在第四季度將其在 Privia Health Group 的持倉增加了 1.3%。Rhumbline Advisers 現在持有 287,200 股公司股票，價值為 5,615,000 美元，此前在上個季度又購買了 3,658 股。Nordea Investment Management AB 在第四季度將其在 Privia Health Group 的股份增加了 33.1%。Nordea Investment Management AB 現在持有 349,773 股公司股票，價值為 6,953,000 美元，此前在上個季度又購買了 86,910 股。Franklin Resources Inc.在第三季度將其在 Privia Health Group 的持股增加了 2.2%。Franklin Resources Inc.現在持有 1,300,240 股公司股票，價值為 23,092,000 美元，此前在上個季度又購買了 28,480 股。巴克萊銀行在第三季度將其在 Privia Health Group 的持股增加了 240.3%。巴克萊銀行現在持有 224,018 股公司股票，價值為 4,079,000 美元，此前在上個季度又購買了 158,188 股。最後，摩根大通在第三季度將其在 Privia Health Group 的持股增加了 8.4%。摩根大通現在持有 188,384 股公司股票，價值為 3,430,000 美元，此前在上個季度又購買了 14,641 股。對沖基金和其他機構投資者持有公司 94.48% 的股票。</p>
<h2>關於 Privia Health Group</h2>
<p>（獲取免費報告）</p>
<p>Privia Health Group, Inc 在美國作為一家全國性的醫生賦能公司運營。該公司與醫療集團、健康計劃和健康系統合作，以優化醫生實踐、提升患者體驗，並獎勵醫生在面對面和虛擬環境中提供護理。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票，優於 Privia Health Group</li>
<li>紐約證券交易所和納斯達克的區別，以及這對投資者的重要性</li>
<li>博通的強勁表現顯示出關税下降中的韌性</li>
<li>選舉股票：選舉如何影響股市</li>
<li>Carvana：能否在逆風中實現反轉？</li>
<li>如何利用分析師評級進行交易</li>
<li>Meta 在 FTC 審判中尋求特朗普的幫助：影響巨大</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UFJWQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UFJWQQ"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Privia Health Group 嗎？</h2>
<p>在考慮 Privia Health Group 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Privia Health Group 並不在名單上。</p>
<p>雖然 Privia Health Group 目前在分析師中獲得 “買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

PRVA

<p>Truist Financial 將 Privia Health Group (NASDAQ:PRVA) 的目標價格從 27.00 美元上調至 28.00 美元，維持 “買入” 評級。這個新目標暗示該股票相較於之前的收盤價有 22.83% 的潛在上漲空間。其他分析師也給予了積極的評級，普遍目標價格為 26.73 美元。Privia Health Group 的股票開盤價為 22.80 美元，市值為 27.7 億美元。最近的內部交易顯示首席財務官 David Mountcastle 出售了部分股份，減少了 3.04% 的持股比例</p>

<p>Privia Health Group (NASDAQ:PRVA - Get Free Report) had its target price boosted by stock analysts at Truist Financial from $27.00 to $28.00 in a report released on Thursday,Benzinga reports. The brokerage presently has a &#34;buy&#34; rating on the stock. Truist Financial's target price points to a potential upside of 22.83% from the stock's previous close.</p>
<div class="lb-trans"><p>Privia Health Group（納斯達克代碼：PRVA - 獲取免費報告）在週四發佈的報告中，Truist Financial 的股票分析師將其目標價格從 27.00 美元上調至 28.00 美元，Benzinga 報道。該券商目前對該股票給予 “買入” 評級。Truist Financial 的目標價格意味着該股票相較於之前的收盤價有 22.83% 的潛在上漲空間。</p>
</div><p>Get <strong>Privia Health Group</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Privia Health Group</strong> 的提醒：</p>
</div><p>PRVA has been the topic of several other reports. Stephens reissued an &#34;overweight&#34; rating and set a $26.00 target price on shares of Privia Health Group in a report on Thursday, January 2nd. Canaccord Genuity Group increased their target price on Privia Health Group from $29.00 to $30.00 and gave the company a &#34;buy&#34; rating in a research report on Friday, February 28th. Macquarie started coverage on Privia Health Group in a research note on Monday, December 16th. They issued an &#34;outperform&#34; rating and a $25.00 price objective for the company. Piper Sandler raised their target price on Privia Health Group from $25.00 to $40.00 and gave the company an &#34;overweight&#34; rating in a report on Friday, February 28th. Finally, JMP Securities set a $29.00 target price on Privia Health Group in a research note on Friday, February 28th. One equities research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of &#34;Buy&#34; and a consensus target price of $26.73.</p>
<div class="lb-trans"><p>PRVA 近期成為多篇報告的主題。Stephens 在 1 月 2 日的報告中重新發布了 “超配” 評級，並將 Privia Health Group 的目標價格設定為 26.00 美元。Canaccord Genuity Group 在 2 月 28 日的研究報告中將 Privia Health Group 的目標價格從 29.00 美元上調至 30.00 美元，並給予該公司 “買入” 評級。Macquarie 在 12 月 16 日的研究報告中開始覆蓋 Privia Health Group，給予 “跑贏大盤” 評級和 25.00 美元的價格目標。Piper Sandler 在 2 月 28 日的報告中將 Privia Health Group 的目標價格從 25.00 美元上調至 40.00 美元，並給予該公司 “超配” 評級。最後，JMP Securities 在 2 月 28 日的研究報告中將 Privia Health Group 的目標價格設定為 29.00 美元。一位股票研究分析師對該股票給予持有評級，十三位給予買入評級，兩位給予強烈買入評級。根據 MarketBeat.com 的數據，該公司目前的共識評級為 “買入”，共識目標價格為 26.73 美元。</p>
</div><p><strong>View Our Latest Stock Report on Privia Health Group</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 Privia Health Group 的最新股票報告</strong></p>
</div><h2>Privia Health Group Trading Down 1.1 %</h2>
<div class="lb-trans"><h2>Privia Health Group 股價下跌 1.1%</h2>
</div><p>PRVA stock opened at $22.80 on Thursday. The business's 50 day simple moving average is $23.73 and its 200 day simple moving average is $21.41. Privia Health Group has a 1-year low of $15.92 and a 1-year high of $26.04. The firm has a market capitalization of $2.77 billion, a PE ratio of 227.97, a PEG ratio of 3.47 and a beta of 0.88.</p>
<div class="lb-trans"><p>PRVA 股票在週四開盤價為 22.80 美元。該公司的 50 日簡單移動平均線為 23.73 美元，200 日簡單移動平均線為 21.41 美元。Privia Health Group 的 1 年最低價為 15.92 美元，1 年最高價為 26.04 美元。該公司的市值為 27.7 億美元，市盈率為 227.97，市盈增長比率為 3.47，貝塔值為 0.88。</p>
</div><h2>Insider Activity at Privia Health Group</h2>
<div class="lb-trans"><h2>Privia Health Group 的內部活動</h2>
</div><p>In other news, CFO David Mountcastle sold 5,630 shares of the firm's stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total value of $125,999.40. Following the completion of the transaction, the chief financial officer now owns 179,676 shares in the company, valued at $4,021,148.88. This trade represents a 3.04 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 14.20% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在其他新聞中，首席財務官 David Mountcastle 在 4 月 2 日（星期三）出售了 5,630 股公司的股票。股票以平均價格 22.38 美元出售，總價值為 125,999.40 美元。交易完成後，首席財務官現在持有 179,676 股公司股票，價值為 4,021,148.88 美元。此交易代表其持股減少了 3.04%。該交易已在向 SEC 提交的文件中披露，文件可通過此超鏈接獲取。公司內部人士目前持有 14.20% 的股票。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>A number of institutional investors and hedge funds have recently made changes to their positions in PRVA. Rhumbline Advisers increased its position in Privia Health Group by 1.3% during the 4th quarter. Rhumbline Advisers now owns 287,200 shares of the company's stock valued at $5,615,000 after buying an additional 3,658 shares in the last quarter. Nordea Investment Management AB increased its stake in Privia Health Group by 33.1% in the 4th quarter. Nordea Investment Management AB now owns 349,773 shares of the company's stock worth $6,953,000 after buying an additional 86,910 shares in the last quarter. Franklin Resources Inc. boosted its holdings in shares of Privia Health Group by 2.2% during the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company's stock valued at $23,092,000 after purchasing an additional 28,480 shares during the last quarter. Barclays PLC grew its holdings in Privia Health Group by 240.3% during the 3rd quarter. Barclays PLC now owns 224,018 shares of the company's stock valued at $4,079,000 after buying an additional 158,188 shares in the last quarter. Finally, JPMorgan Chase &amp; Co. grew its holdings in Privia Health Group by 8.4% during the 3rd quarter. JPMorgan Chase &amp; Co. now owns 188,384 shares of the company's stock valued at $3,430,000 after buying an additional 14,641 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company's stock.</p>
<div class="lb-trans"><p>一些機構投資者和對沖基金最近對 PRVA 的持倉進行了調整。Rhumbline Advisers 在第四季度將其在 Privia Health Group 的持倉增加了 1.3%。Rhumbline Advisers 現在持有 287,200 股公司股票，價值為 5,615,000 美元，此前在上個季度又購買了 3,658 股。Nordea Investment Management AB 在第四季度將其在 Privia Health Group 的股份增加了 33.1%。Nordea Investment Management AB 現在持有 349,773 股公司股票，價值為 6,953,000 美元，此前在上個季度又購買了 86,910 股。Franklin Resources Inc.在第三季度將其在 Privia Health Group 的持股增加了 2.2%。Franklin Resources Inc.現在持有 1,300,240 股公司股票，價值為 23,092,000 美元，此前在上個季度又購買了 28,480 股。巴克萊銀行在第三季度將其在 Privia Health Group 的持股增加了 240.3%。巴克萊銀行現在持有 224,018 股公司股票，價值為 4,079,000 美元，此前在上個季度又購買了 158,188 股。最後，摩根大通在第三季度將其在 Privia Health Group 的持股增加了 8.4%。摩根大通現在持有 188,384 股公司股票，價值為 3,430,000 美元，此前在上個季度又購買了 14,641 股。對沖基金和其他機構投資者持有公司 94.48% 的股票。</p>
</div><h2>About Privia Health Group</h2>
<div class="lb-trans"><h2>關於 Privia Health Group</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.</p>
<div class="lb-trans"><p>Privia Health Group, Inc 在美國作為一家全國性的醫生賦能公司運營。該公司與醫療集團、健康計劃和健康系統合作，以優化醫生實踐、提升患者體驗，並獎勵醫生在面對面和虛擬環境中提供護理。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Privia Health Group</li>
<li>How the NYSE and NASDAQ are Different, Why That Matters to Investors</li>
<li>Broadcom's Big Outperformance Shows Strength Amid Tariff Decline</li>
<li>Election Stocks: How Elections Affect the Stock Market</li>
<li>Carvana: Can Turnaround Strength Outdrive Market Headwinds?</li>
<li>How to trade using analyst ratings</li>
<li>Meta Seeks Trump's Help in FTC Trial: The Implications Are Huge</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，優於 Privia Health Group</li>
<li>紐約證券交易所和納斯達克的區別，以及這對投資者的重要性</li>
<li>博通的強勁表現顯示出關税下降中的韌性</li>
<li>選舉股票：選舉如何影響股市</li>
<li>Carvana：能否在逆風中實現反轉？</li>
<li>如何利用分析師評級進行交易</li>
<li>Meta 在 FTC 審判中尋求特朗普的幫助：影響巨大</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UFJWQQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=PRVA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Privia Health Group Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Privia Health Group 嗎？</h2>
</div><p>Before you consider Privia Health Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Privia Health Group 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Privia Health Group 並不在名單上。</p>
</div><p>While Privia Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Privia Health Group 目前在分析師中獲得 “買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Truist Financial 的分析師表示，Privia Health Group（納斯達克股票代碼：PRVA）的股價預計將上漲